Market Place
Sourcing Support
Porton Pharma and Aojin Partner on XDC Conjugate Drug Development
11 Dec 2024 //
PRESS RELEASE
Porton Pharma Earns Sustainability Acclaim Among Chinese Firms
06 Dec 2024 //
PRESS RELEASE
Porton Pharma Launches Refreshed Official Website
06 Dec 2024 //
PRESS RELEASE
Porton Pharma Signed Strategic Partnership with Shanghai InnoStar
24 Oct 2024 //
PRESS RELEASE
Porton And Genentech Publish Breakthrough In Crystallization Research
05 Jul 2024 //
PRESS RELEASE
Porton Experts Join U Of Perugia`s PRO-API Program For Green Chemistry
29 Jun 2024 //
PRESS RELEASE
Porton J-STAR Partners With ETC On Co-Processing Platform Tech Development
28 Jun 2024 //
PRESS RELEASE
Porton Will Be Participating In Biotech Outsourcing Strategies Events This June
06 Jun 2024 //
PRESS RELEASE
Porton Pharma Solutions Embark On The Next Frontier In Mengeš, Slovenia
23 May 2024 //
PRESS RELEASE
Proton At CPhI North America Again
16 May 2024 //
PRESS RELEASE
Upcoming Porton Shows In Europe And The USA：Shaping Our Future Together
19 Apr 2024 //
PRESS RELEASE
Porton Makes Debut At DCAT Week 2024
28 Mar 2024 //
PRESS RELEASE
Porton Pharma Solutions Joined The SBTi To Drive Climate Action
02 Mar 2024 //
PRESS RELEASE
Porton Advanced Announces a Strategic Partnership with BioMap
08 Nov 2023 //
PR NEWSWIRE
PCS Is Held Annually To Bring Together Developers Of New Medicines
28 Sep 2023 //
PRESS RELEASE
Porton Pharma Announces New Flagship Facility Offering API Crystallization
13 Sep 2023 //
PRESS RELEASE
Pharma Digital Intelligence Summit Will Be Held On 5th, September, 2023
29 Aug 2023 //
PRESS RELEASE
Dr. Angelo Maria Manzo of Porton Pharma Solutions Joins BOS Basel 2023, Spearheading Collaborations
19 Jun 2023 //
PRESS RELEASE
Porton Pharma Solutions Launches State-of-the-Art Small Molecule Platform in Shanghai, Elevating CDMO Services
19 Jun 2023 //
PRESS RELEASE
Porton Pharma Solutions Expands Global Reach with New Site in Slovenia and Enhanced Manufacturing Capabilities
19 Jun 2023 //
PRESS RELEASE
Porton Unveils Its Small Molecule Platform Headquarters In Shanghai
14 May 2023 //
PRESS RELEASE
Porton Starts Construction of Its Facility For Antibodies And ADCs In Shanghai
17 Apr 2023 //
PRESS RELEASE
Porton Delivers Strong 2022 Performance With 127% Sales Growth
25 Mar 2023 //
PRESS RELEASE
Porton Released 2022 CSR Report
25 Mar 2023 //
PRESS RELEASE
China’s Porton to set up biotech park in Slovenia’s Menges
10 Jan 2023 //
INTELLINEWS
Porton Pharma Solutions Recognized by Roche Group as a Leading CDMO Service Provider
16 Dec 2022 //
PRESS RELEASE
Porton Reports Strong Interim Results 2022
23 Aug 2022 //
PRESS RELEASE
Porton raises funds for gene and cell therapy CDMO platforms expansion
23 Aug 2022 //
PHARMACEUTICAL-TECHNOLOGY
Porton Pharma Solutions Ltd. to Expand Operations in Europe
12 Aug 2022 //
PRESS RELEASE
How to Choose the Right Cell and Gene Therapy CDMO
02 May 2022 //
GENENGNEWS
Porton Announced To Acquire China Gateway Pharmaceutical Development
11 Mar 2022 //
PRESS RELEASE
Porton Plans To Invest 420 Million To Expand CDMO Production Capacity Of Small Molecule API
02 Mar 2022 //
PRESS RELAESE
Porton Invests To Expand API CDMO Capacity
10 Feb 2022 //
PRESS RELEASE
Porton Expects Strongly Growth In Revenue And Net Profit In 2021
10 Jan 2022 //
PRESS RELEASE
Porton Announces Acquisition Of Yuyang Pharmaceutical To Expand Its Manufacturing Capacity
18 Aug 2021 //
PRESS RELEASE
CfPC Announces Program Of 2021 Pharmaceutical Crystallization Summit(Reproduced)
24 Jun 2021 //
PRESS RELEASE
WS109, Porton’s New Multi-Purpose CGMP API Workshop Goes On Stream
20 Jun 2021 //
PRESS RELEASE
Porton Biologics Announces Closing Series-A Financing To Drive Commercial Production Of Gene And Cell Therapy
16 Apr 2021 //
PRESS RELEASE
Porton Launches An Integrated CGMP Solutions Suite At Its Chongqing Process Technology Center, China
21 May 2020 //
PRESS RELEASE
Porton Successfully Receives Third US FDA Inspection.
21 Apr 2020 //
PRESS RELEASE
Porton’s Successfully Executes Process Validation Of A Major NCE Drug For A Global Pharmaceutical Company
08 Apr 2020 //
PRESS RELEASE
CDMO PharmaBlock purchases Chinese facility to meet increasing demand
02 Oct 2018 //
OUTSOURCING-PHARMA
Porton Pharma Solutions and Codexis launch global partnership
27 Apr 2018 //
EUROPEANPHARMACEUTICAL REVIEW
Codexis and Porton Pharma announce strategic collaboration
23 Apr 2018 //
THEFLY
